FDA Approval Timeline for Diabetes and Weight Loss The FDA granted approval for semaglutide (Ozempic brand) as a weekly injection for type 2 diabetes on December 5, 2017
Autoimmune antibodies, including anti-smooth muscle antibodies, anti-nuclear antibodies, anti-histone antibodies, and anti-double-stranded DNA (dsDNA) antibodies are also increased in PCOS patients (68)
Beginning July 1, 2026, the Centers for Medicare & Medicaid Services (CMS) will launch the Medicare GLP-1 Bridge Program, a temporary demonstration designed to provide eligible Medicare Part D beneficiaries with access to certain GLP-1 medications through December 31, 2027
Glutathione: The Most Powerful Antioxidant You may recall my discussion of free radicals in a recent blog
Lyophilized, sealed under inert gas, US shipping with 15% Bitcoin discount
Renal : acute kidney injury Skin and Subcutaneous Tissue : alopecia DRUG INTERACTIONS Oral Medications : OZEMPIC delays gastric emptying